Candidates for a Fairbanks City Council seat and the mayor’s office touched on several topics during the annual Tanana Valley League of Women Voters forum on Friday, including vital city services, ...

ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...

SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first participant in the ECLIPSE 2 Phase 3 clinical trial, which is designed to compare the ...

`[This story originally appeared in the June 2006 issue of MotorTrend] There's something wrong here--and so right it hurts. A two-ton sedan shouldn't do the things a world-class sports car does. Want ...

The sky's orange and green glows cast a "tie-dye" effect around the moon's outline. In March, observers in Chile were treated to an especially spectacular sight, as the night sky lit up with orange ...

The New York Irish Center is presenting five hours of music and dance set against the backdrop of Queens at the fourth annual Queens Irish Heritage Festival from 4 pm to 9 pm this Saturday, June 14.

(RTTNews) - Northrop Grumman Corp. (NOC), Thursday announced that it has committed $50 million to Firefly Aerospace to accelerate production of their jointly developed medium class launch vehicle, ...

CEO Marianne De Backer emphasized Vir's progress in advancing its infectious disease and oncology programs. Key milestones include initiating the ECLIPSE Phase III registrational program for hepatitis ...

HENDERSON, Nev., May 7, 2025 /PRNewswire/ -- AEROCOR, LLC is proud to announce its official partnership with the Eclipse Jet Owners and Pilots Association (EJOPA) to deliver a Flight Operational ...

First patient enrolled in ECLIPSE 1 Phase 3 clinical trial evaluating combination of tobevibart and elebsiran for chronic suppressive treatment ECLIPSE program designed to enable regulatory ...

SAN FRANCISCO--(BUSINESS WIRE)-- Vir Biotechnology, Inc. (VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE registrational program. The ECLIPSE registrational program is ...